Roche Holding, CH0012032048

Roche Holding stock holds near its yearly high

Published on 09/23/2026 at 12:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Roche Holding stock traded at CHF 360.60 on September 22, 2026, down 0.22 percent. Berenberg kept its CHF 350 target on September 23.

Automatisches Diagnostik-Laborgerät mit Touchscreen-Oberfläche im klinischen Labor — Roche Holding AG CH0012032048 – Diagnostik-Analysegerät verarbeitet biologische Proben im modernen klinischen Labor, Illustration mit AI erstellt.

Roche Holding AG (CH0012032048) traded at CHF 360.60 on the SIX on September 22, 2026, down CHF 0.80 or 0.22 percent from the prior close. The price remained below the 52-week high of CHF 375.80 and above the 52-week low of CHF 252.20.

Berenberg keeps a neutral view

According to MarketScreener on September 23, 2026, Berenberg analyst Luisa Hector maintained a Neutral rating and a CHF 350 price target. That target is CHF 10.60 below the September 22 closing price, while the five-analyst average target was CHF 375.34, CHF 14.74 above the same close.

The valuation spread is material: the highest target in the cited consensus was CHF 434.50 and the lowest was CHF 230.00. The range between those estimates is CHF 204.50, showing that the consensus average masks a wide difference in expectations.

Sales estimates remain measurable

MarketScreener financial estimates published on September 23, 2026, list Roche revenue at CHF 62.657 billion for fiscal year 2026, compared with CHF 61.516 billion for fiscal year 2025, an increase of CHF 1.141 billion or 1.9 percent.MarketScreener

The same estimate set puts 2026 EBITDA at CHF 25.287 billion, up from CHF 24.608 billion in fiscal year 2025. EBITDA growth of CHF 679 million is more modest than the share price distance from the 52-week low, so the stock valuation depends on both earnings delivery and confidence in the longer-term pipeline.

Stock stays below the 52-week high

MarketWatch reported a CHF 287.67 billion market capitalization and a 52-week range of CHF 252.20 to CHF 375.80 for Roche on September 22, 2026. The cited volume was 1.53 million shares against a 65-day average of 937,460 shares, or approximately 63 percent above that average.MarketWatch

For investors, the key tension is visible in the numbers: the September 22 price was CHF 108.40, or 43.0 percent, above the 52-week low, yet CHF 15.20, or 4.0 percent, below the 52-week high. Berenberg's CHF 350 target sits CHF 10.60 below the latest close, whereas the average target points to CHF 375.34.

Roche Holding stock closes at CHF 360.60

Roche Holding stock closed at CHF 360.60 on the SIX on September 22, 2026, down 0.22 percent on the day. The market capitalization was CHF 287.67 billion and the reported volume was 1.53 million shares as of the same market-data snapshot.